PHC Launches LiCellMoTM Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies

Contributed by: Business Wire

Logo

Images

Left: Controller (MLC-AC0-P*) / Right: Detector (MLC-AD240A-P*) / Bottom: Sensor module (MLC-AS240A-PW) (Graphic: Business Wire)

Business Wire embedded0

Tags

Stem Cells

Biotechnology

Technology

Manufacturing

Health

Pharmaceutical

Oncology

Medical Devices

Other Manufacturing

Genetics

Hardware

PHC Corporation

More Like This

(Graphic: Business Wire)

PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support Development of Cell and Gene Therapy Products Manufacturing Process

PR Newswire associated0

Hamamatsu Photonics introduces CYTOQUBE, a new cell analyzer combining light-sheet optics and image analysis in a fast, user-friendly system for 3D cell screening assays

CytoTronics is launching its high-throughput Pixel™ Octo system (right) at the International Society for Stem Cell Research (ISSCR 2024) in Hamburg, Germany. The ISSCR conference also marks the European reveal of CytoTronics’ product portfolio, including the entry-level Pixel Primo (left), a single plate reader that brings accessibility to researchers. (Photo: Business Wire)

CytoTronics Breaks Scalability Barriers for Monitoring Live Cell Function, Reveals Pixel Octo for High-Throughput Cell Biology Discovery Applications

PR Newswire associated0

CELLSEARCH® CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer

PR Newswire associated0

Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

MEGAROBO Unveils High-Content Cell Imaging System for Advanced Multidimensional Biological Analysis

PR Newswire associated0

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

PR Newswire associated0

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing